Prostate Cancer
Recent Abstracts
Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center.
June 21, 2024
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center.
June 21, 2024
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer.
June 21, 2024
Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163].
June 21, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial.
June 21, 2024
Impact of Mental Health Illness Prior to Prostate Cancer Diagnosis on Treatment Received and Prostate Cancer Outcomes
June 20, 2024
Germline Gene-Specific Associations in a Large Prostate Cancer Cohort
June 20, 2024
Informed Decision-Making About Germline Testing Among Veterans with Advanced Prostate Cancer: A Mixed-Methods Study
June 20, 2024
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy.
June 20, 2024
Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer.
June 20, 2024
Machine Learning to Predict Prostate Artery Embolization Outcomes.
June 20, 2024
Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages.
June 19, 2024
The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.
June 19, 2024
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN).
June 19, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
June 19, 2024
Estimating the Effect of Radical Prostatectomy: Combining Data From the SPCG4 and PIVOT Randomized Trials With Contemporary Cohorts.
June 19, 2024
Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial.
June 19, 2024
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
June 18, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancer.
June 18, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage.
June 18, 2024
Page 7 of 1406
Start
Prev
2
3
4
5
6
7
8
9
10
11
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free